ACADIAN TIMBER CORP (ADN.CA) Stock Fundamental Analysis
TSX:ADN - Toronto Stock Exchange - CA0042721005 - Common Stock - Currency: CAD
Overall ADN gets a fundamental rating of 5 out of 10. We evaluated ADN against 12 industry peers in the Paper & Forest Products industry. While ADN belongs to the best of the industry regarding profitability, there are concerns on its financial health. ADN has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year ADN was profitable.
ADN had a positive operating cash flow in the past year.
ADN had positive earnings in each of the past 5 years.
Each year in the past 5 years ADN had a positive operating cash flow.
1.2 Ratios
ADN has a better Return On Assets (3.19%) than 91.67% of its industry peers.
The Return On Equity of ADN (5.70%) is better than 91.67% of its industry peers.
The Return On Invested Capital of ADN (2.48%) is better than 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ADN is in line with the industry average of 3.92%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.19% | ||
| ROE | 5.7% | ||
| ROIC | 2.48% |
ROA(3y)5.08%
ROA(5y)4.63%
ROE(3y)9.11%
ROE(5y)8.26%
ROIC(3y)2.69%
ROIC(5y)2.83%
1.3 Margins
ADN has a better Profit Margin (17.26%) than 100.00% of its industry peers.
ADN's Profit Margin has improved in the last couple of years.
The Operating Margin of ADN (18.25%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of ADN has declined.
With an excellent Gross Margin value of 31.36%, ADN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of ADN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.25% | ||
| PM (TTM) | 17.26% | ||
| GM | 31.36% |
OM growth 3Y-3.67%
OM growth 5Y-1.71%
PM growth 3Y-1.44%
PM growth 5Y1.58%
GM growth 3Y0.77%
GM growth 5Y0.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ADN is destroying value.
ADN has more shares outstanding than it did 1 year ago.
ADN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ADN has a worse debt to assets ratio.
2.2 Solvency
ADN has an Altman-Z score of 1.29. This is a bad value and indicates that ADN is not financially healthy and even has some risk of bankruptcy.
ADN has a Altman-Z score of 1.29. This is comparable to the rest of the industry: ADN outperforms 41.67% of its industry peers.
The Debt to FCF ratio of ADN is 4.85, which is a neutral value as it means it would take ADN, 4.85 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ADN (4.85) is better than 66.67% of its industry peers.
ADN has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
ADN has a Debt to Equity ratio (0.34) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | 4.85 | ||
| Altman-Z | 1.29 |
ROIC/WACC0.38
WACC6.49%
2.3 Liquidity
A Current Ratio of 1.16 indicates that ADN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.16, ADN is doing worse than 83.33% of the companies in the same industry.
A Quick Ratio of 0.94 indicates that ADN may have some problems paying its short term obligations.
ADN has a Quick ratio (0.94) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The earnings per share for ADN have decreased strongly by -35.63% in the last year.
ADN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.80% yearly.
Looking at the last year, ADN shows a quite strong growth in Revenue. The Revenue has grown by 12.30% in the last year.
Measured over the past years, ADN shows a small growth in Revenue. The Revenue has been growing by 3.05% on average per year.
EPS 1Y (TTM)-35.63%
EPS 3Y4.63%
EPS 5Y-9.8%
EPS Q2Q%-40%
Revenue 1Y (TTM)12.3%
Revenue growth 3Y6.68%
Revenue growth 5Y3.05%
Sales Q2Q%-13.8%
3.2 Future
The Earnings Per Share is expected to decrease by -4.83% on average over the next years.
ADN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.01% yearly.
EPS Next Y-15.83%
EPS Next 2Y-8.92%
EPS Next 3Y-5.48%
EPS Next 5Y-4.83%
Revenue Next Year-4.47%
Revenue Next 2Y-3.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 16.21 indicates a correct valuation of ADN.
83.33% of the companies in the same industry are more expensive than ADN, based on the Price/Earnings ratio.
ADN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.61.
Based on the Price/Forward Earnings ratio of 17.36, the valuation of ADN can be described as rather expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as ADN.
Compared to an average S&P500 Price/Forward Earnings ratio of 37.13, ADN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.21 | ||
| Fwd PE | 17.36 |
4.2 Price Multiples
ADN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ADN is more expensive than 66.67% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ADN is valued a bit cheaper than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.65 | ||
| EV/EBITDA | 20.73 |
4.3 Compensation for Growth
The excellent profitability rating of ADN may justify a higher PE ratio.
ADN's earnings are expected to decrease with -5.48% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.92%
EPS Next 3Y-5.48%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.38%, ADN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.75, ADN pays a better dividend. On top of this ADN pays more dividend than 91.67% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, ADN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.38% |
5.2 History
The dividend of ADN decreases each year by -10.56%.
ADN has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of ADN decreased recently.
Dividend Growth(5Y)-10.56%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
ADN pays out 53.45% of its income as dividend. This is a bit on the high side, but may be sustainable.
ADN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP53.45%
EPS Next 2Y-8.92%
EPS Next 3Y-5.48%
TSX:ADN (7/30/2025, 7:00:00 PM)
18.15
-0.02 (-0.11%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)
Earnings (Next)
Inst Owners9.34%
Inst Owner ChangeN/A
Ins Owners0.66%
Ins Owner ChangeN/A
Market Cap326.34M
Analysts76.67
Price Target19.38 (6.78%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.38% |
Yearly Dividend0.66
Dividend Growth(5Y)-10.56%
DP53.45%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)96.99%
Min EPS beat(2)29.95%
Max EPS beat(2)164.03%
EPS beat(4)2
Avg EPS beat(4)35.71%
Min EPS beat(4)-43.07%
Max EPS beat(4)164.03%
EPS beat(8)6
Avg EPS beat(8)140.24%
EPS beat(12)10
Avg EPS beat(12)184.65%
EPS beat(16)12
Avg EPS beat(16)136.59%
Revenue beat(2)1
Avg Revenue beat(2)4.73%
Min Revenue beat(2)-2.31%
Max Revenue beat(2)11.76%
Revenue beat(4)2
Avg Revenue beat(4)10.02%
Min Revenue beat(4)-9.02%
Max Revenue beat(4)39.67%
Revenue beat(8)3
Avg Revenue beat(8)5.83%
Revenue beat(12)4
Avg Revenue beat(12)0.39%
Revenue beat(16)7
Avg Revenue beat(16)1.41%
PT rev (1m)0%
PT rev (3m)-7.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-35.9%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.21 | ||
| Fwd PE | 17.36 | ||
| P/S | 2.91 | ||
| P/FCF | 13.65 | ||
| P/OCF | 11.7 | ||
| P/B | 0.96 | ||
| P/tB | 0.98 | ||
| EV/EBITDA | 20.73 |
EPS(TTM)1.12
EY6.17%
EPS(NY)1.05
Fwd EY5.76%
FCF(TTM)1.33
FCFY7.33%
OCF(TTM)1.55
OCFY8.54%
SpS6.24
BVpS18.89
TBVpS18.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.19% | ||
| ROE | 5.7% | ||
| ROCE | 3.45% | ||
| ROIC | 2.48% | ||
| ROICexc | 2.5% | ||
| ROICexgc | 2.53% | ||
| OM | 18.25% | ||
| PM (TTM) | 17.26% | ||
| GM | 31.36% | ||
| FCFM | 21.3% |
ROA(3y)5.08%
ROA(5y)4.63%
ROE(3y)9.11%
ROE(5y)8.26%
ROIC(3y)2.69%
ROIC(5y)2.83%
ROICexc(3y)2.73%
ROICexc(5y)2.88%
ROICexgc(3y)2.76%
ROICexgc(5y)2.92%
ROCE(3y)3.75%
ROCE(5y)3.95%
ROICexcg growth 3Y0.45%
ROICexcg growth 5Y-5.14%
ROICexc growth 3Y0.47%
ROICexc growth 5Y-5.06%
OM growth 3Y-3.67%
OM growth 5Y-1.71%
PM growth 3Y-1.44%
PM growth 5Y1.58%
GM growth 3Y0.77%
GM growth 5Y0.08%
F-Score5
Asset Turnover0.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | 4.85 | ||
| Debt/EBITDA | 5.46 | ||
| Cap/Depr | 611.37% | ||
| Cap/Sales | 3.55% | ||
| Interest Coverage | 6.08 | ||
| Cash Conversion | 131.95% | ||
| Profit Quality | 123.4% | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | 1.29 |
F-Score5
WACC6.49%
ROIC/WACC0.38
Cap/Depr(3y)780.67%
Cap/Depr(5y)518.79%
Cap/Sales(3y)3.37%
Cap/Sales(5y)2.17%
Profit Quality(3y)61.15%
Profit Quality(5y)72.04%
High Growth Momentum
Growth
EPS 1Y (TTM)-35.63%
EPS 3Y4.63%
EPS 5Y-9.8%
EPS Q2Q%-40%
EPS Next Y-15.83%
EPS Next 2Y-8.92%
EPS Next 3Y-5.48%
EPS Next 5Y-4.83%
Revenue 1Y (TTM)12.3%
Revenue growth 3Y6.68%
Revenue growth 5Y3.05%
Sales Q2Q%-13.8%
Revenue Next Year-4.47%
Revenue Next 2Y-3.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.3%
EBIT growth 3Y2.77%
EBIT growth 5Y1.28%
EBIT Next Year14.35%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y111.36%
FCF growth 3Y13.98%
FCF growth 5YN/A
OCF growth 1Y139.15%
OCF growth 3Y28.01%
OCF growth 5YN/A